Research on HIV & the Immune System: Archive 1993-1997

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

It's Time to Approve More Surrogate Markers (March 21, 1997)
From AIDS Treatment News
Backstepped: Dutch Challenge to Ho/Shaw HIV Model (February 7, 1997)
From Treatment Action Group
Can HIV be Eradicated? (January 1997)
Presented by Dr. David Ho.
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
HIV in Genital Secretions -- Part 1 (January 1997)
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
HIV in Genital Secretions -- Part 2 (January 1997)
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
HIV in Lymphoid Tissue, and More from November's NIH AIDS Panel (January 1997)
From Treatment Action Group
Immune Modulation Therapy with IL-2 and IL-12 (Winter 1996/1997)
In STEP Perspective, from Seattle Treatment Education Project
Dr. Robert Schooley on HIV Eradication (December 1996)
From Treatment Action Group
Honing the Immune Attack on HIV (December 1996)
Research on therapeutic vaccines.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Novel HIV Strategies Previewed (December 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Clues to Non-Progressors (November 1996)
Flurry of Discoveries in Multiple Labs Leads to Identification of HIV's Second Receptor -- And New Therapeutic Target.
From Treatment Action Group
Outrunning HIV to Protect Immune Defenses (November 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
CKR-5: New Study Confirms Some Do Not Get HIV (October, 1996)
In AIDS Treatment News, from AIDS Treatment News
Genetic Mutation Appears to Confer Immunity to HIV (October, 1996)
In HIV Newsline, from San Francisco General Hospital
CKR-5 -- Understanding the News (September 6, 1996)
In AIDS Treatment News, from AIDS Treatment News
Long-Awaited Research Paper Takes on the Viral Diversity Threshold, Cannibalistic CTLs and NSI-to-SI Switch (July 1996)
In TAGline, from Treatment Action Group
Be Kind to Your Chemokines (June/July 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Immunologic Factors & Therapy (report from the XIth International AIDS Conference) (Summer 1996)
In STEP Perspective, from Seattle Treatment Education Project
Viral Dynamics (report from the XIth International AIDS Conference) (Summer 1996)
In STEP Perspective, from Seattle Treatment Education Project
Viral Resistance (report from the XIth International AIDS Conference) (Summer 1996)
In STEP Perspective, from Seattle Treatment Education Project
NIH Scientists Find Cofactor for HIV Entry (May 17, 1996)
In AIDS Treatment News, from AIDS Treatment News
Primary Infection (Spring 1996)
In STEP Perspective, from Seattle Treatment Education Project
HIV Suppressors Found in Cells (January 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Report on Drug Development from the HIV Immune-based Therapies Workshop (March 1995)
In TAGline, from Treatment Action Group
Pulling the Plug on T-Cells: Work on HIV and T-Cell Kinetics Challenges Longtime Dismissal of Ravaged Immune System's Regenerative Potential (February 1995)
In TAGline, from Treatment Action Group
Yokohama Pathogenesis Update: Improved Clinical Outcomes Wrought by Immunosuppressive Medicine and Second-Rate Immune Responses (October, 1994)
On immune response to HIV infection, and corresponding disease progression.
In TAGline, from Treatment Action Group
Imprecise Science Key to Ignorance About HIV? (August 1994)
In TAGline, from Treatment Action Group
Would-Be Discovers of Cytokine Switch Taken to Task (August 1994)
In TAGline, from Treatment Action Group
Basic Research on HIV Infection: A Report From the Front (June 1993)
From Treatment Action Group

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.